Edison, NJ, United States of America

Richard L Kendall


Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 316(Granted Patents)


Location History:

  • Thousand Oaks, CA (US) (2001 - 2002)
  • Doylestown, PA (US) (2001 - 2005)
  • Edison, NJ (US) (1998 - 2011)

Company Filing History:


Years Active: 1998-2011

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Richard L. Kendall: Innovating in Vascular Biology

Introduction

Richard L. Kendall is a notable inventor based in Edison, NJ, recognized for his contributions to the field of vascular biology. With an impressive portfolio of 12 patents, Kendall has made significant advancements, particularly in the area of inhibitors for vascular endothelial cell growth factor (VEGF). His inventions are aimed at understanding and controlling endothelial cell growth, which is crucial in various medical applications.

Latest Patents

Among his latest patents, Kendall developed inhibitors of vascular endothelial cell growth factor. These inhibitors are characterized as naturally occurring or recombinantly engineered soluble forms of the receptor for VEGF, which is a highly selective growth factor for endothelial cells. The soluble forms bind the VEGF with high affinity, effectively inhibiting its function without initiating signal transduction. This groundbreaking work has the potential to lead to novel therapeutic strategies in treating conditions associated with abnormal vascular growth.

Career Highlights

Throughout his career, Richard L. Kendall has had a profound impact on medicinal and biological sciences. He has held important positions at reputable organizations, including Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His work has not only added to the understanding of vascular biology but has also paved the way for innovative treatments.

Collaborations

Kendall has collaborated with various talented individuals in the field. Notable coworkers include Kenneth A. Thomas, Jr., and Xianzhi Mao, who have contributed to the research and development of his innovative projects. These collaborations highlight the importance of teamwork in driving scientific advancements.

Conclusion

Richard L. Kendall's work embodies the spirit of innovation in medical research. His patents in VEGF inhibition reveal both his expertise and his commitment to addressing challenges in vascular health. As he continues to contribute to the field, Kendall remains a significant figure in the landscape of biomedical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…